Literature DB >> 22940718

[Surgical treatment of male lower urinary tract symptoms (LUTS)].

C Gratzke1, F Strittmatter, O Reich, A Bachmann, C G Stief, M Seitz.   

Abstract

Surgical treatment of lower urinary tract symptoms (LUTS) due to benign prostatic obstruction (BPO) comprises a variety of treatment modalities. Transurethral resection of the prostate (TURP) is considered the gold standard. In the last decade various new techniques have emerged with encouraging functional results. However, long-term data are missing in order to evaluate the efficacy and safety. This review aims to describe new widely available techniques and to assess the underlying evidence.

Entities:  

Mesh：

Year:  2012        PMID： 22940718     DOI： 10.1007/s00120-012-2959-6

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  41 in total

Review 1.  A systematic review of holmium laser prostatectomy for benign prostatic hyperplasia.

Authors:  Rebecca Tooher; Peter Sutherland; Anthony Costello; Peter Gilling; Guy Rees; Guy Maddern
Journal:  J Urol       Date:  2004-05       Impact factor: 7.450

2.  After three randomised controlled trials comparing 120-W high-performance-system potassium-titanyl-phosphate laser vaporisation to transurethral resection of the prostate (TURP), is this procedure finally first-line, outdated, or still not surpassing TURP?

Authors:  Stephan Madersbacher
Journal:  Eur Urol       Date:  2012-02-25       Impact factor: 20.096

3.  Mortality after transurethral and open prostatectomy in Scotland.

Authors:  T B Hargreave; C F Heynes; S W Kendrick; B Whyte; J A Clarke
Journal:  Br J Urol       Date:  1996-04

4.  Bipolar plasmakinetic transurethral resection of prostate in 132 consecutive patients with large gland: three-year follow-up results.

Authors:  Guangbin Zhu; Changying Xie; Xinghuan Wang; Xiuquan Tang
Journal:  Urology       Date:  2011-10-27       Impact factor: 2.649

5.  GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up.

Authors:  Carlos Capitán; Cristina Blázquez; M Dolores Martin; Virginia Hernández; Enrique de la Peña; Carlos Llorente
Journal:  Eur Urol       Date:  2011-06-01       Impact factor: 20.096

6.  Laparoscopic extraperitoneal simple prostatectomy for benign prostate hyperplasia: a two-year experience.

Authors:  Bulent Oktay; Gokhan Koc; Hakan Vuruskan; Mahmut Esad Danisoglu; Yakup Kordan
Journal:  Urol J       Date:  2011       Impact factor: 1.510

7.  Interventional therapies for lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH).

Authors:  M Seitz; M Bader; D Tilki; C Stief; C Gratzke
Journal:  Minerva Urol Nefrol       Date:  2012-06       Impact factor: 3.720

Review 8.  Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement.

Authors:  Sascha A Ahyai; Peter Gilling; Steven A Kaplan; Rainer M Kuntz; Stephan Madersbacher; Francesco Montorsi; Mark J Speakman; Christian G Stief
Journal:  Eur Urol       Date:  2010-06-11       Impact factor: 20.096

9.  Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.

Authors:  Moritz F Hamann; Carsten M Naumann; Christof Seif; Christof van der Horst; Klaus-Peter Jünemann; Peter M Braun
Journal:  Eur Urol       Date:  2008-05-16       Impact factor: 20.096

10.  The diode laser: a novel side-firing approach for laser vaporisation of the human prostate--immediate efficacy and 1-year follow-up.

Authors:  Michael Seitz; Ronald Sroka; Christian Gratzke; Boris Schlenker; Verena Steinbrecher; Wael Khoder; Derya Tilki; Alexander Bachmann; Christian Stief; Oliver Reich
Journal:  Eur Urol       Date:  2007-06-26       Impact factor: 20.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.